← back to database
Foresite Capital
HQ · California
Multi-stage healthcare and life-sciences investing, backing breakthrough companies at the intersection of technology and biotech, using data science, biological insights and a multidisciplinary scientific investment team; invests from incubation through IPO and beyond.
Stage focus
Lead / follow
Specialization
Generalist / Specialist
Specialist
Latest fund size
$900M — Foresite Capital Fund VI
Latest fund vintage
2024
Investing team
- Jim Tananbaum, MDFounder & CEO
- Michael Rome, PhDManaging Director
- Dorothy Margolskee, MDManaging Director
- Stephen C. Peterson, CFAManaging Director
- Richard Lau, CFAManaging Director
- Hyung Chun, MDPartner
- Shannon BergstedtPartner
- Deepak Atri, MDPrincipal
- Vishal Deshmukh, PhDPrincipal
- Insiya EssaniSenior Associate
- Melia Granath PaneloAssociate
- Collin Yang-WongPrincipal
- Liang Chang, PhDVenture Partner
- Mike Lai, MDVenture Partner
- Uplaksh KumarVenture Partner
- Jorge Reis-Filho, MD, PhD, FRCPathVenture Partner
- Peter Wung, MD, MHSVenture Partner
- Travis Young, PhDVenture Partner
Notable investments
April 4, 2025: RayThera completed its $110M launch Series A co-led by Foresite Capital and OrbiMed; RayThera was founded in August 2023.
Sources
foresitecapital.com/strategy ↗foresitecapital.com/contact ↗foresitecapital.com/people ↗foresitecapital.com/news/portfolio-news/raythera-launches-with-110-million-to-advance-immunology-pipeline ↗foresitecapital.com/portfolio/raythera ↗businesswire.com/news/home/20250404667548/en/RayThera-Raises-110-Million-in-Series-A-Financing ↗foresitecapital.com/news/press-releases/foresite-capital-raises-900m-to-invest-in-healthcare-and-life-science-startups-at-all-stages ↗foresitecapital.com/people/michael-rome-phd ↗foresitecapital.com/people/stephen-c-peterson-cfa ↗foresitecapital.com/people/hyung-chun-md ↗foresitecapital.com/people/shannon-bergstedt ↗linkedin.com/company/foresite-capital-management ↗adviserinfo.sec.gov/firm/summary/162823 ↗foresitecapital.com ↗